Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$101.14 USD
-2.01 (-1.95%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $101.28 +0.14 (0.14%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 1.18 |
EPS Last Quarter | 1.40 |
Last EPS Surprise | 27.27% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.71 |
Next Year | 5.90 |
EPS (TTM) | 4.67 |
P/E (F1) | 21.47 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 37.12M | 40.27M | 155.10M | 166.69M |
# of Estimates | 2 | 2 | 1 | 2 |
High Estimate | 38.27M | 44.30M | 155.10M | 174.00M |
Low Estimate | 35.97M | 36.23M | 155.10M | 159.37M |
Year ago Sales | 32.87M | 28.10M | 131.31M | 155.10M |
Year over Year Growth Est. | 12.93% | 43.29% | 18.11% | 7.47% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.18 | 1.23 | 4.71 | 5.90 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 1.18 | 1.23 | 4.71 | 5.90 |
High Estimate | 1.18 | 1.23 | 4.71 | 5.90 |
Low Estimate | 1.18 | 1.23 | 4.71 | 5.90 |
Year ago EPS | 1.02 | 1.05 | 4.06 | 4.71 |
Year over Year Growth Est. | 15.69% | 17.14% | 16.01% | 25.27% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.18 | 1.23 | 4.71 | 5.90 |
7 Days Ago | 1.18 | 1.23 | 4.71 | 5.90 |
30 Days Ago | 1.18 | 1.23 | 4.71 | 5.90 |
60 Days Ago | 1.18 | 1.23 | 4.71 | 5.90 |
90 Days Ago | 1.18 | 1.23 | 4.71 | 5.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.18 | 1.23 | 4.71 | 5.90 |
Zacks Consensus Estimate | 1.18 | 1.23 | 4.71 | 5.90 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.40 | 1.20 | 1.05 | 1.02 | NA |
Estimate | 1.10 | 1.13 | 0.58 | 0.68 | NA |
Difference | 0.30 | 0.07 | 0.47 | 0.34 | 0.30 |
Surprise | 27.27% | 6.19% | 81.03% | 50.00% | 41.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more